પ્રોસ્ટેટ કેન્સર
A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC)
ક્યાં જવું
આ ટ્રાયલ માટે ભારતમાં 8 હોસ્પિટલો દર્દીઓ લઈ રહી છે.
રજિસ્ટ્રી સમરી (ટેકનિકલ)
Researchers are looking for a better way to treat men who have non-metastatic castration-resistant prostate cancer (nmCRPC). This is a type of cancer of the prostate that has not yet spread to other parts of the body and that keeps progressing even when the amount of male sex hormones like testosterone (also called androgens) is reduced to very low levels. To reduce androgen levels in prostate cancer patients, androgen deprivation therapy (ADT) is often used. As androgens stimulate the growth of prostate cancer cells, low levels are needed to reduce or slow the growth of these tumors. In men …
સ્પોન્સર: Bayer
ClinicalTrials.gov પર NCT05348876
રજિસ્ટ્રીમાં છેલ્લે અપડેટ 6 જુલાઈ 2026 · અમે 20 ઓક્ટોબર 2026 ના રોજ વાંચ્યું